The curative properties attributed to marihuana for several thousand pars h
ave proved to be disappointing. The ancient oriental claims of marihuana as
a pain soother and for the relief of muscle spasms, convulsions, rheumatis
m, epilepsy and migraine headaches were introduced into western medicine du
ring the 19th century. The reason for the lack of success with marihuana re
medies at that time was the same as the present observations encountered wi
th THC and all of its novel applications: the variability and inconsistency
of its effects associated with unwanted psychological and cardiovascular e
ffects. The discovery of THC, the active ingredient of marihuana gave a new
impetus for an intensive search for its potential therapeutic applications
. THC and its psychoactive derivatives were proposed as analgesic, antidepr
essant, hypnotic tranquilizer, as a treatment for withdrawal symptoms, glau
coma, spasticity, nausea, vomiting, and to enhance the appetite. Marihuana
smoke, in spite of its toxicity to the lung and immune system, was even adv
ocated by some as a medically acceptable vehicle for THC. For many of these
therapeutic applications, molecular pharmacologists have been able to tail
or specific molecules targeted to receptor sites which control acute and in
flammatory pain, nausea, vomiting, and glaucoma. These fundamental studies
in molecular pharmacology have also provided for an explanation of the ther
apeutic inadequacy of THC. This cannabinoid deregulates the physiological s
ignaling role of a receptor protein to which it binds and of the membrane b
ilipid layer which it permeates. This deregulation of membrane signaling wi
ll result in discordant and partial therapeutic effects coupled with unwant
ed side effects.